Skip to main content

Find Clinical Trials

Home
Conditions
3rd Line GIST

Clinical trial condition

3rd Line GIST

Explore clinical trials studying 3rd Line GIST. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

3rd Line GIST trial results

Completed

A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients

NCT01468688

Conditions: 3rd Line GIST
Locations: Dana Farber Cancer Institute SC (2) Boston, Massachusetts, United States

Seattle Cancer Care Alliance Onc Seattle, Washington, United States

Novartis Investigative Site Leuven, Belgium

Novartis Investigative Site Vancouver, British Columbia, Canada

View Trial Details

Completed

A Dose-finding Study of a Combination of Imatinib and BYL719 in the Treatment of 3rd Line GIST Patients

NCT01735968

Conditions: 3rd Line GIST
Locations: Oregon Health and Science University Dept. of OHSU (3) Portland, Oregon, United States

Novartis Investigative Site Leuven, Belgium

Novartis Investigative Site Bordeaux, France

Novartis Investigative Site Berlin, Germany

View Trial Details